ACTRIMS-ECTRIMS: Alemtuzumab Slowed Brain Atrophy in MS Patients
Physician's Weekly,
Benefit observed in patients with or without disease…
Benefit observed in patients with or without disease…
TweetJAMA 21 Nov 2012 Vol 308 OPERA is the quintessential Italian art-form: devised as a return to the classical past, it is…
Cohen et al. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple…
Posted on behalf of Duncan Graham-Rowe. It is what multiple sclerosis sufferers have long hoped for, a drug that can not only…